Respiratory

Latest News

Man holding paper model of lungs | Image credit: Elena - stock.adobe.com

Depemokimab Reduces Exacerbations Regardless of Baseline Asthma Control

By Jared Kaltwasser

July 3rd 2025

Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being reviewed by the FDA.

Given the observed outcomes, camlipixant merits further study in severe RCC, especially among patients with a high initial cough burden. | Image credit: sebra - stock.adobe.com

Camlipixant May Benefit Patients With High-Burden RCC

By Kimberly Rath, PharmD

June 25th 2025

Man having asthma attack on couch | Image credit: Pixel-Shot – stock.adobe.com

Solrikitug Shows Promise as Next-Generation Anti-TSLP Therapy in Asthma, COPD

By Hayden E. Klein

June 25th 2025

A comprehensive home-based program integrating weekly telecounseling and individually tailored breathing exercise training reduced hospitalizations among patients with COPD. | Image credit: Ahmad - stock.adobe.com

Telehealth Model Reduces Hospital Admissions in COPD

By Kimberly Rath, PharmD

June 18th 2025

FDA Approval | Image credit: BHM – stock.adobe.com

FDA Approves Clesrovimab to Prevent RSV in Infants During First Season

By Hayden E. Klein

June 10th 2025

Continuing Medical Education

July 4th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

July 4th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

July 4th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

July 4th 2025

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology

July 4th 2025

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology

July 4th 2025

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology

July 4th 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

March 16th 2018

Assessing Medical Home Mechanisms: Certification, Asthma Education, and Outcomes

Nathan D. Shippee, PhD Michael Finch, PhD Douglas R. Wholey, PhD

Using statewide quality data for medical home–eligible clinics, we tested asthma education as a clinical mechanism whereby medical homes achieve better asthma outcomes.

February 17th 2018

Claims-Based Risk Model for First Severe COPD Exacerbation

Richard H. Stanford, PharmD, MS Arpita Nag, PhD, MBA, MS Douglas W. Mapel, MD Todd A. Lee, PhD Richard Rosiello, MD Michael Schatz, MD Francis Vekeman, MS Marjolaine Gauthier-Loiselle, PhD J.F. Philip Merrigan, PhD Mei Sheng Duh, ScD

A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.

Respimat Is First Inhaler to Receive Award for Ease of Use for People With Arthritis

January 24th 2018

Respimat Is First Inhaler to Receive Award for Ease of Use for People With Arthritis

Respimat from Boehringer Ingelheim is now the first and only inhaler to be awarded the Ease of Use Commendation by the Arthritis Foundation. This award identifies products that make life easier for people with arthritis and other physical limitations.

Researchers Make COPD Genetic Discovery That Could Identify At-Risk Patients Earlier

January 16th 2018

Researchers Make COPD Genetic Discovery That Could Identify At-Risk Patients Earlier

Allison Inserro

Cigarette smoking is the most common cause of chronic obstructive pulmonary disease (COPD), but not all smokers develop the condition, and many non-smokers do. Why that is has remained a mystery until now, as a research team, funded by the National Institutes of Health, has discovered genetic variations in the anatomy of the lungs could serve as early-warning indicators.

CDC Study Puts Economic Burden of Asthma at More Than $80 Billion Per Year

January 12th 2018

CDC Study Puts Economic Burden of Asthma at More Than $80 Billion Per Year

Allison Inserro

Asthma costs the U.S. economy more than $80 billion annually in medical expenses, days missed from work and school, and deaths, according to research published online in the Annals of the American Thoracic Society. However, actual numbers are likely to be higher, according to CDC researchers who conducted the study.

Study Shows Psychological Factors Affect Quality of Life in Patients With COPD

January 10th 2018

Study Shows Psychological Factors Affect Quality of Life in Patients With COPD

Psychological factors negatively affect quality-of-life scores in chronic obstructive pulmonary disease (COPD) patients, according to a recent study published in the International Journal of Chronic Obstructive Pulmonary Disease.

Study Shows the Efficacy of Vaccination in Patients With COPD

January 3rd 2018

Study Shows the Efficacy of Vaccination in Patients With COPD

Patients with chronic obstructive pulmonary disease should be given the pneumococcal conjugate vaccine and influenza vaccines to decrease the risk of exacerbations. However, despite the evidence of vaccine efficacy, improvements are needed in coverage and awareness.

Researchers Find Low Referral Rates to Pulmonary Rehab for Eligible Patients With COPD

December 25th 2017

Researchers Find Low Referral Rates to Pulmonary Rehab for Eligible Patients With COPD

Christina Mattina

Less than 10% of patients with chronic obstructive pulmonary disease (COPD) who may benefit from pulmonary rehabilitation received a referral from their physician, according to a new study. However, there was no association found between referral status and COPD exacerbations.

Boxed Warning for Asthma Death Risk Removed From ICS/LABA Drugs

December 24th 2017

Boxed Warning for Asthma Death Risk Removed From ICS/LABA Drugs

The FDA has removed a boxed warning on medicines delivering a combinations of inhaled corticosteroid (ICS) and long-acting beta agonists (LABA) drugs.

Study Finds Breathing Retraining Associated With Quality of Life Improvement for Patients With Asthma

December 14th 2017

Study Finds Breathing Retraining Associated With Quality of Life Improvement for Patients With Asthma

Laura Joszt, MA

Despite effective pharmacology, many patients with asthma have impaired quality of life, but a new breathing retraining intervention can be used as a nonpharmacological intervention to treat asthma.

FDA Announces Public Education Campaign to Encourage Smoking Cessation

December 14th 2017

FDA Announces Public Education Campaign to Encourage Smoking Cessation

Jaime Rosenberg

The FDA has announced its launch of the “Every Try Counts” campaign, which will encourage smokers to quit by advertising messages of support underscoring the health benefits of quitting. The campaign will also focus on celebrating each quit attempt as a step towards success.

December 8th 2017

Implications of DRG Classification in a Bundled Payment Initiative for COPD

Trisha M. Parekh, DO Surya P. Bhatt, MD Andrew O. Westfall, MS James M. Wells, MD deNay Kirkpatrick, DNP, APN-BC Anand S. Iyer, MD Michael Mugavero, MD James H. Willig, MD Mark T. Dransfield, MD

Diagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.

Identifying Differences of Symptoms of Patients With Severe COPD in 3 Countries

December 5th 2017

Identifying Differences of Symptoms of Patients With Severe COPD in 3 Countries

Laura Joszt, MA

A study of patients with severe chronic obstructive pulmonary disease (COPD) in Poland, The Republic of Korea, and the United States identified substantial differences in respiratory symptoms and other respiratory illnesses.

Identifying the Most Prevalent and Costly Chronic Conditions in Medicaid

November 29th 2017

Identifying the Most Prevalent and Costly Chronic Conditions in Medicaid

Laura Joszt, MA

High prevalence of chronic conditions has been a key driver of healthcare costs in the United States, and Medicaid beneficiaries tend to have higher rates of chronic diseases than people not on Medicaid.

Eosinophil Count in Sputum, Not Blood, Is Better Predictor of COPD Severity in Smokers

November 21st 2017

Eosinophil Count in Sputum, Not Blood, Is Better Predictor of COPD Severity in Smokers

Christina Mattina

Data from a study of smokers with chronic obstructive pulmonary disease (COPD) indicate that the concentration of eosinophils in the sputum, rather than the blood, is a better predictor of COPD exacerbations and lung function.

Impact of Symptoms and COPD Severity on Health-Related Quality of Life

November 14th 2017

Impact of Symptoms and COPD Severity on Health-Related Quality of Life

Laura Joszt, MA

Chronic obstructive pulmonary disease (COPD) is characterized by persistent and progressive airflow limitation, and a new study examined the factors responsible for a high St George’s Respiratory Questionnaire for COPD based on severity of airflow limitation.

Long-Term Oxygen Therapy Can Improve Survival in Patients With Oxygen-Dependent COPD

November 9th 2017

Long-Term Oxygen Therapy Can Improve Survival in Patients With Oxygen-Dependent COPD

Surabhi Dangi-Garimella, PhD

A new study has shown that long-term oxygen therapy in patients with severe alpha-1 antitrypsin deficiency can improve survival; however, their outcomes do not improve following lung-transplantation.

Study Finds a 47% Increased Risk of COPD Hospitalization Among RA Patients

November 1st 2017

Study Finds a 47% Increased Risk of COPD Hospitalization Among RA Patients

Alison Rodriguez

Previous studies have revealed a potential connection between chronic inflammatory conditions and the predisposition of chronic obstructive pulmonary disease (COPD), and a new study has found that patients with rheumatoid arthritis (RA) are associated with a greater risk of COPD hospitalization compared to the general population.

Study Investigates New COPD Categories With GOLD 2017

October 26th 2017

Study Investigates New COPD Categories With GOLD 2017

Alison Rodriguez

New high-risk groups of patients with chronic obstructive pulmonary disease according to GOLD 2017 were found to have more characteristics related to acute exacerbation and mortality risks.

October 4th 2017

Study Links Anxiety and Depression Symptoms to COPD Patients and Caregivers

Alison Rodriguez

Patients suffering from chronic obstructive pulmonary disease and their caretakers may experience symptoms of anxiety and depression that could impact their mortality, quality of life, and healthcare use.

September 26th 2017

Chronic Respiratory Disease Death Toll Rising in Recent Decades

Christina Mattina

A new analysis finds that the mortality rate from chronic respiratory diseases has risen by almost 30% between 1980 and 2014 in the United States, and that data reflect significant differences in death rates across counties and regions.

August 1st 2017

Gastric Bypass Sharply Lowers Death Risk for People With Diabetes, Study Finds

The reduced mortality risk was not seen in patients who did not have diabetes before surgery. But in those who did, the results were dramatic.

May 23rd 2017

Adding Home-Based Ventilation to COPD Therapy Can Prolong Time to Readmission, Death

Christina Mattina

A JAMA study has found that patients with chronic obstructive pulmonary disease (COPD) who received noninvasive ventilation in addition to home oxygen therapy went longer without being readmitted to the hospital or dying than those who received only home oxygen therapy.

March 17th 2017

Catching a Cold Poses Risk of Symptom Exacerbation in COPD Patients

Christina Mattina

For patients with chronic obstructive pulmonary disease (COPD), catching a cold is often more than just an annoyance; their risk of experiencing COPD symptom exacerbation rises 30-fold when they exhibit signs of a cold.

February 18th 2017

New Collaboration to Promote Discovery of Innovative Respiratory Therapies

Christina Mattina

Weill Cornell Medicine and Boehringer Ingelheim have announced a collaboration that will investigate novel approaches to treating chronic respiratory disease.

January 9th 2014

Smoking and Health at 50: A Public Health Milestone

EBRC takes a special look at Smoking and Health, the 1964 report to the Surgeon General that forever changed how this country thought about cigarettes, on the eve of its 50th anniversary.

October 11th 2013

Express Scripts Stops Covering Key Big Pharma Drugs on Clinical, Cost-Effectiveness Grounds

A few weeks ago, Novo Nordisk ($NVO) said it had lost Express Scripts' business on two of its top drugs, Victoza and NovoLog. Well, that was just part of the action at the pharmacy benefits manager.

June 26th 2013

Climate Change Bill Gives Hope to Help Asthma, Other Ills

...

17 18 19 20 21 22 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions